Compared to MAPT participants, preDIVA participants were significantly younger, had significantly higher mean CAIDE dementia risk scores; BMI, and SBP; more often had a history of diabetes, stroke, and heart disease; and were more likely to be male, be APOE ε4 carriers, and have untreated hypertension. This evidence concerns the gene APOE and stroke disorder.